62 related articles for article (PubMed ID: 1355384)
1. Effect of methylxanthine derivatives on T cell activation.
Singer JW; Bianco JA; Takahashi G; Simrell C; Petersen J; Andrews DF
Bone Marrow Transplant; 1992 Jul; 10(1):19-25. PubMed ID: 1355384
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of pentoxifylline on the production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) by monocytes and T cells.
Schandené L; Vandenbussche P; Crusiaux A; Alègre ML; Abramowicz D; Dupont E; Content J; Goldman M
Immunology; 1992 May; 76(1):30-4. PubMed ID: 1385797
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-2 induces tumor necrosis factor-alpha production by activated human T cells via a cyclosporin-sensitive pathway.
Lorré K; Fransen L; Ceuppens JL
Eur Cytokine Netw; 1992; 3(3):321-30. PubMed ID: 1353987
[TBL] [Abstract][Full Text] [Related]
4. Effects of pentoxifylline on differentiation, maturation, and function of human CD14+ monocyte-derived dendritic cells.
Zhang R; Bharadwaj U; Li M; Chen C; Yao Q
J Immunother; 2007 Jan; 30(1):89-95. PubMed ID: 17198087
[TBL] [Abstract][Full Text] [Related]
5. Immune response modulation by pentoxifylline in vitro.
Tilg H; Eibl B; Pichl M; Gächter A; Herold M; Brankova J; Huber C; Niederwieser D
Transplantation; 1993 Jul; 56(1):196-201. PubMed ID: 8333042
[TBL] [Abstract][Full Text] [Related]
6. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
[TBL] [Abstract][Full Text] [Related]
7. Different regulatory effects of pentoxifylline on human T cell activation pathways.
Dong RP; Umezawa Y; Ikushima H; Munakata Y; Schlossman SF; Morimoto C
J Clin Immunol; 1997 May; 17(3):247-52. PubMed ID: 9168405
[TBL] [Abstract][Full Text] [Related]
8. IL-7 drives donor T cell proliferation and can costimulate cytokine secretion after MHC-matched allogeneic bone marrow transplantation.
Levy RB; Jones M; Hamilton BL; Paupe J; Horowitz T; Riley R
J Immunol; 1995 Jan; 154(1):106-15. PubMed ID: 7995931
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory properties of pentoxifylline are mediated via adenosine-dependent pathways.
Kreth S; Ledderose C; Luchting B; Weis F; Thiel M
Shock; 2010 Jul; 34(1):10-6. PubMed ID: 19997047
[TBL] [Abstract][Full Text] [Related]
10. The effect of hydroxychloroquine on alloreactivity and its potential use for graft-versus-host disease.
Gilman AL; Beams F; Tefft M; Mazumder A
Bone Marrow Transplant; 1996 Jun; 17(6):1069-75. PubMed ID: 8807116
[TBL] [Abstract][Full Text] [Related]
11. Regulation of tumor necrosis factor (TNF)-alpha synthesis and TNF receptors expression in T lymphocytes through the CD2 activation pathway.
Santis AG; Campanero MR; Alonso JL; Sánchez-Madrid F
Eur J Immunol; 1992 Dec; 22(12):3155-60. PubMed ID: 1359970
[TBL] [Abstract][Full Text] [Related]
12. Anti-class II -DR humanized monoclonal antibody, IMMU-114, blocks allogeneic immune response.
Park KH; Sawada T; Murakami T; Ishii Y; Yasuo M; Fuchinoue S; Goldenberg DM; Kubota K
Am J Surg; 2012 Oct; 204(4):527-34. PubMed ID: 22658578
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory effect of pentoxifylline during human allograft rejection: involvement of tumor necrosis factor-alpha and adhesion molecules.
Noel C; Copin MC; Hazzan M; Labalette M; Susen S; Lelievre G; Dessaint JP
Transplantation; 2000 Mar; 69(6):1102-7. PubMed ID: 10762214
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo soluble fas ligand treatment of donor cells to selectively reduce murine acute graft versus host disease.
Georgantas RW; Bohana-Kashtan O; Civin CI
Transplantation; 2006 Aug; 82(4):471-8. PubMed ID: 16926590
[TBL] [Abstract][Full Text] [Related]
15. Pentoxifylline inhibits adhesion and activation of human T lymphocytes.
González-Amaro R; Portales-Pérez D; Baranda L; Redondo JM; Martínez-Martínez S; Yáñez-Mó M; García-Vicuña R; Cabañas C; Sánchez-Madrid F
J Immunol; 1998 Jul; 161(1):65-72. PubMed ID: 9647208
[TBL] [Abstract][Full Text] [Related]
16. Defective interleukin 2 receptor expression is associated with the T cell disfunction subsequent to bone marrow transplantation.
López-Botet M; De Landazuri MO; Izquierdo M; Ramirez A; Cámara R; Fernández-Rañada J
Eur J Immunol; 1987 Aug; 17(8):1167-74. PubMed ID: 3113980
[TBL] [Abstract][Full Text] [Related]
17. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Li JM; Gorechlad J; Larsen CP; Waller EK
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
[TBL] [Abstract][Full Text] [Related]
18. Pentoxifylline inhibits Vgamma9/Vdelta2 T lymphocyte activation of patients with active Behçets disease in vitro.
Accardo-Palumbo A; Ferrante A; Ciccia F; Cadelo M; Giardina AR; Impastato R; Triolo G
Int J Immunopathol Pharmacol; 2007; 20(3):601-6. PubMed ID: 17880773
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation.
Martin PJ; Pei J; Gooley T; Anasetti C; Appelbaum FR; Deeg J; Hansen JA; Nash RA; Petersdorf EW; Storb R; Ghetie V; Schindler J; Vitetta ES
Biol Blood Marrow Transplant; 2004 Aug; 10(8):552-60. PubMed ID: 15282533
[TBL] [Abstract][Full Text] [Related]
20. Effects of treating marrow with a CD3-specific immunotoxin for prevention of acute graft-versus-host disease.
Martin PJ; Hansen JA; Torok-Storb B; Moretti L; Press O; Storb R; Thomas ED; Weiden PL; Vitetta ES
Bone Marrow Transplant; 1988 Sep; 3(5):437-44. PubMed ID: 2973360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
